Women were more (64.3%) and their medianage and digoxin concentrations were higher (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Introduction: Digoxin monitoring is important in the elderly because of thetoxicity risk.
📊
Key Findings & Data:The aim of this study was to evaluate the orders made by different unitsfor digoxin monitoring in the elderly.Materials and Method: Digoxin orders and results in patients aged over 65,patients’ demographic characteristics, such as age and gender, the unit from whichthe order was made, and patients’ pre-diagnoses were retrospectively recorded.Patients were divided into young-old, middle-old, and very-old groups, and theresults were divided into subtherapeutic, therapeutic, and toxic levels.Results: The percentage of young-old, middle-old, and very-old patients was39.4%, 45.3%, and 15.3%, respectively.
💡
Conclusion & Impact:Women were more (64.3%) and their medianage and digoxin concentrations were higher (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Introduction: Digoxin monitoring is important in the elderly because of thetoxicity risk. The aim of this study was to evaluate the orders made by different unitsfor digoxin monitoring in the elderly.Materials and Method: Digoxin orders and results in patients aged over 65,patients’ demographic characteristics, such as age and gender, the unit from whichthe order was made, and patients’ pre-diagnoses were retrospectively recorded.Patients were divided into young-old, middle-old, and very-old groups, and theresults were divided into subtherapeutic, therapeutic, and toxic levels.Results: The percentage of young-old, middle-old, and very-old patients was39.4%, 45.3%, and 15.3%, respectively. Women were more (64.3%) and their medianage and digoxin concentrations were higher (p
🔖
Cite This Article
YILMAZ, İ., BOZKAYA, G., BİLGİLİ, S. (2022). EVALUATION OF DIGOXIN LEVELS IN ELDERLY PATIENTS IN A TRAINING HOSPITAL: AN 11-YEAR FOLLOW-UP. Türk Geriatri Dergisi, Cilt: 23 - Sayı: 1, 108–117. https://ajindex.com/articles/623578
Cheng JW, Rybak I. Use of digoxin for heart failure and atrial fibrillation in elderly patients. Am J Geriatr Pharmacother 2010;8(5):419-27. (PMID:21335295)
Ilerigelen B. Heart failure in elderly. Turkish Journal of Geriatrics 2010;13(Supplement 2):21-32. (in Turkish)
Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002;41(5):329-42. (PMID:12036391)
Puche Canas E, Aomar Millan I, Carrillo Santos JC. Inappropriate blood levels of digoxin in a study of 2,849 patients from a teaching hospital: the influence of age and sex. An Med Interna 2004;21(12):581-4. (PMID:15628952)
Ahmed A. Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations. J Gerontol A Biol Sci Med Sci 2007;62(3):323-9. (PMID:17389731)
Kang JS, Lee MH. Overview of therapeutic drug monitoring. Korean J Intern Med 2009;24(1):1-10. (PMID:19270474)
Currie GM, Wheat JM, Kiat H. Pharmacokinetic considerations for digoxin in older people. Open Cardiovasc Med J 2011;5:130-5. (PMID:21769303)
Miura T, Kojima R, Sugiura Y, Mizutani M, Takatsu F, Suzuki Y. Effect of aging on the incidence of digoxin toxicity. Ann Pharmacother 2000;34(4):427-32. (PMID:10772425)
Hafner JW Jr, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002;39(3):258-67. (PMID:11867978)
Budnitz DS, Shehab N, Kegler SR, Richards CL. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007;147(11):755-65. (PMID:18056659)
Bernard DW, Bowman RL, Grimm FA, Wolf BA, Simson MB, Shaw LM. Nighttime dosing assures postdistribution sampling for therapeutic drug monitoring of digoxin. Clin Chem 1996;42(1):45-9. (PMID:8565231)
Ozturk Z, Cuhadar S. Evaluation and clinical significance of factors affecting the serum digoxin levels in patients taking digoxin. Bezmialem Science 2018;6:31-6. (in Turkish)
Sillars A, Ho FK, Pell GP, et al. Sex differences in the association of risk factors for heart failure incidence and mortality. Heart 2020;106(3):203-12. (PMID:31366573)
Garcia-Iranzo EM, Rodriguez-Lucena FJ, Matoses- Chirivella C, Garcia-Monsalve A, Murcia-Lopez AC, Navarro-Ruiz A. Pharmacokinetic monitoring of chronic treatment with digoxin from primary health care. Farm Hosp 2017;41(4):527-32. (PMID:28683704)